Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC
Accepted 2024-03-04 00:00:00 ET · period of report 2024-02-29 · accession 0001062993-24-005212 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-04 | 2024-02-29 | COLL | Smith Thomas B | EVP, Chief Medical Off | S - Sale | $36.76 | -995 | 63.4K | -2% | -$36.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-29 | S | D | 995 | $36.76 | 63,409 | D | — | — |